Obstetrics/Gynecology Topics
RSSArticles
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Science Focuses on Mycoplasma genitalium
Mycoplasma genitalium, a sexually transmitted infection, is a major cause of urethritis in men and is associated with cervicitis, pelvic inflammatory disease, preterm birth, and spontaneous abortion in women.
-
New Study Points to Long-term Effectiveness of 9-Valent HPV Vaccine
Vaccine could prevent 90% of cervical cancer cases worldwide.
-
HIV Pre-exposure Prophylaxis for Adolescents: A Health Equity and Reproductive Justice Issue
Access to HIV pre-exposure prophylaxis is not just a public health issue, but equally important, an equity and justice issue.
-
Low Rates of Adherence to PID Guidance Found in Emergency Departments
Research analyzing trends in the nation’s emergency departments indicates low rates of HIV and syphilis screening among teens diagnosed with pelvic inflammatory disease, despite the high risk for such infections. Data also suggest low rates of adherence to national treatment guidelines.
-
Clinician Alert: STIs Hit High-water Mark
More than 2 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2016, the highest number ever, according to the latest surveillance from the Centers for Disease Control and Prevention.
-
U.S. MEC Updates Contraceptive Information for Women With HIV
The Centers for Disease Control and Prevention is revising its recommendation on the use of the progestin-only contraception injection depot medroxyprogesterone acetate (DMPA) by women at high risk for HIV from Category 1 (no restriction) to Category 2 (benefits outweigh theoretical or proven risks).
-
Task Force Issues Cervical Cancer Screening Guidance: What Changes Can Clinicians Expect?
Ages 30-65: Cervical cytology every three years or HPV testing every five years.
-
Medicaid Waivers Pose New Threats to Reproductive Health
State policymakers around the country are pursuing changes to Medicaid that could have serious implications for healthcare access.
-
Vaginal Estrogen Found to Be Safe, Effective Option During Menopause
Results of recent research indicate that vaginal estrogen is effective and safe for the treatment of genitourinary symptoms. Such low-dose vaginal estrogen options keep blood levels within the normal postmenopausal range.